KRAS and malignant colon neoplasm: Similar TCR therapies are in progress for KRAS G12V-mutated colon cancer and NSCLC (NCT06043713), TP53 R175H-mutated solid tumors (NCT05877599), and KRAS G12D-mutated tumors (NCT06218914).